Pituitary & hypothalamus

Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium

Eur J EndocrinolPublished Retrospective cohort study

Authors' conclusion

Probability of micro-NFPA growth is low, and the development of new hypopituitarism is rare. Delaying the first follow-up MRI to 3 years and avoiding hormonal re-evaluation in the absence of tumour growth or clinical manifestations is a safe approach for micro-NFPA surveillance.

Study context

Population
Patients with non-functioning pituitary microadenomas (micro-NFPAs), January 1, 2008 to December 21, 2021; median age at detection 44 years (IQR 31–57), 152 males/307 females419 with >2 magnetic resonance imagings (MRIs)
Participants
459 patients
Outcome
Natural history of micro-NFPAs: cumulative probability of growth
Methodological detailsmulticentre, 23 endocrine departments (UK NFPA consortium)
  • Multicentre
  • 23 endocrine departments (UK NFPA consortium)

Main finding

As reported in the abstract

Cumulative probability of micro-NFPA growth · 3 and 5 years
Growth at 3 years
7.8% (95% CI, 4.9%-8.1%)
Growth at 5 years
14.5% (95% CI, 10.2%-18.8%)
Reduction at 3 years
14.1% (95% CI, 10.4%-17.8%)
Reduction at 5 years
21.3% (95% CI, 16.4%-26.2%)
Median tumour enlargement
2 mm (IQR 1-3)
Micro-NFPAs that grew becoming macroadenomas (nearly all >5 mm at detection)
49%

Observational data: associations, not effects.

Further findings

Predictors of enlargement/reduction

Sex, age and size at baseline were not predictors of enlargement/reduction

Hypopituitarism at detection

Secondary hypogonadism
7.2%
Hypothyroidism
1.7%
Hypoadrenalism
1.5%

Surgery

Patients receiving surgery
8 (1.9%)
  • Only one had visual compromise, with surgery required >3 years after detection

Safety

Apoplexy
1 case
New hypopituitarism during follow-up (after progression to macroadenoma)
2 (0.6%)

Original publication

Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. Eur J Endocrinol. Published 22 June 2023. doi:10.1093/ejendo/lvad070

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.